Authors:
Chakrabarti, P
Wong, HY
Toyofuku, A
Scantlebury, VP
Jordan, ML
Vivas, C
Jain, AB
McCauley, J
Johnston, J
Randhawa, PS
Hakala, TR
Simmons, RL
Fung, JJ
Starzl, TE
Shapiro, R
Citation: P. Chakrabarti et al., Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression, TRANSPLAN P, 33(1-2), 2001, pp. 1235-1236
Authors:
McCauley, J
Shapiro, R
Jordan, ML
Scantlebury, VP
Vivas, C
Jain, A
Good, D
Woods, H
Johnston, J
Corry, RJ
Citation: J. Mccauley et al., Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression, TRANSPLAN P, 33(1-2), 2001, pp. 1698-1699
Authors:
Soran, A
Basar, H
Shapiro, R
Vivas, C
Scantlebury, VP
Jordan, ML
Gritsch, HA
McCauley, J
Randhawa, P
Hakala, TR
Fung, JJ
Citation: A. Soran et al., Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression, TRANSPLAN P, 32(3), 2000, pp. 663-664
Authors:
Chakrabarti, P
Wong, HY
Scantlebury, VP
Jordan, ML
Vivas, C
Ellis, D
Lombardozzi-Lane, S
Hakala, TR
Fung, JJ
Simmons, RL
Starzl, TE
Shapiro, R
Citation: P. Chakrabarti et al., Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression, TRANSPLANT, 70(5), 2000, pp. 760-764
Authors:
Randhawa, PS
Minervini, AI
Lombardero, M
Duquesnoy, R
Fung, J
Shapiro, R
Jordan, M
Vivas, C
Scantlebury, V
Demetris, A
Citation: Ps. Randhawa et al., Biopsy of marginal donor kidneys: Correlation of histologic findings with graft dysfunction, TRANSPLANT, 69(7), 2000, pp. 1352-1357
Authors:
Jordan, ML
Shapiro, R
Vivas, C
Scantlebury, V
McCauley, J
McMichael, J
Randhawa, P
Demetris, A
Fung, J
Starzl, TE
Citation: Ml. Jordan et al., Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up, TRANSPLAN P, 31(7A), 1999, pp. 81S-83S
Authors:
Shapiro, R
Jordan, ML
Scantlebury, VP
Vivas, C
Marsh, JW
McCauley, J
Johnston, J
Randhawa, P
Irish, W
Gritsch, HA
Naraghi, R
Hakala, TR
Fung, JJ
Starzl, TE
Citation: R. Shapiro et al., A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up, TRANSPLAN P, 31(1-2), 1999, pp. 1134-1134
Authors:
Ellis, D
Jaffe, R
Green, M
Janosky, JJ
Lombardozzi-Lane, S
Shapiro, R
Scantlebury, V
Vivas, C
Jordan, ML
Citation: D. Ellis et al., Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression, TRANSPLANT, 68(7), 1999, pp. 997-1003
Authors:
Shapiro, R
Nalesnik, M
McCauley, J
Fedorek, S
Jordan, ML
Scantlebury, VP
Jain, A
Vivas, C
Ellis, D
Lombardozzi-Lane, S
Randhawa, P
Johnston, J
Hakala, TR
Simmons, RL
Fung, JJ
Starzl, TE
Citation: R. Shapiro et al., Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression, TRANSPLANT, 68(12), 1999, pp. 1851-1854
Authors:
Shapiro, R
Jordan, ML
Scantlebury, VP
Vivas, C
Marsh, JM
McCauley, J
Johnston, J
Randhawa, P
Irish, W
Gritsch, HA
Naraghi, R
Hakala, TR
Fung, JJ
Starzl, TE
Citation: R. Shapiro et al., A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone mycophenolate mofetil in renal transplant recipients, TRANSPLANT, 67(3), 1999, pp. 411-415
Authors:
Shapiro, R
Scantlebury, VP
Jordan, ML
Vivas, C
Ellis, D
Lombardozzi-Lane, S
Gilboa, N
Gritsch, HA
Irish, W
McCauley, J
Fung, JJ
Hakala, TR
Simmons, RL
Starzl, TE
Citation: R. Shapiro et al., Pediatric renal transplantation under tacrolimus-based immunosuppression, TRANSPLANT, 67(2), 1999, pp. 299-303